RNA logo

Avidity Biosciences (RNA) Revenue

Annual revenue:

$10.90M+$1.34M(+13.99%)
December 31, 2024

Summary

  • As of today (May 29, 2025), RNA annual revenue is $10.90 million, with the most recent change of +$1.34 million (+13.99%) on December 31, 2024.
  • During the last 3 years, RNA annual revenue has risen by +$1.57 million (+16.85%).
  • RNA annual revenue is now at all-time high.

Performance

1-year change

+13.99%

3-year change

+16.85%

5-year change

+369.9%

15-year change

+2775.2%

RNA Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

29.06%
RNA annual revenue is higher than 29.06% of companies in Healthcare sector

Analysts estimate

$7.39M
RNA annual revenue is currently +47.55% higher than the consensus analysts' forecast

Range

All-time high

$10.90M
RNA annual revenue is currently at an all-time high

3-year low

$9.22M
RNA annual revenue is currently +18.14% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
RNA previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
RNA next annual earnings announcement has not yet been scheduled

OtherRNAincome statement metrics

Annual EPS

-$2.89
RNA annual earnings per share is -$2.89

annual net income

-$322.30M
RNA annual net profit is -$322.30 million

annual operating profit

-$378.94M
RNA annual operating income is -$378.94 million

Annual gross profit

-
RNA annual gross profit value is unknown

Quarterly revenue:

$1.57M-$1.40M(-47.09%)
March 31, 2025

Summary

  • As of today (May 29, 2025), RNA quarterly revenue is $1.57 million, with the most recent change of -$1.40 million (-47.09%) on March 31, 2025.
  • Over the past year, RNA quarterly revenue has dropped by -$1.97 million (-55.60%).
  • RNA quarterly revenue is now -55.60% below its all-time high of $3.54 million, reached on March 31, 2024.

Performance

3-month change

-47.09%

1-year change

-55.6%

3-year change

-12.37%

5-year change

+15.83%

RNA Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

20.23%
RNA quarterly revenue is higher than 20.23% of companies in Healthcare sector

Analysts estimate

$1.61M
RNA quarterly revenue is currently -2.21% lower than the consensus analysts' forecast

Range

All-time high

$3.54M
RNA quarterly revenue is currently -55.60% below its historical high of $3.54 million

3-year low

$1.57M
RNA quarterly revenue is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
RNA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
RNA next earnings announcement is scheduled for Aug 8, 2025

OtherRNAincome statement metrics

quarterly gross profit

-
RNA quarterly gross profit value is unknown

quarterly operating profit

-$131.52M
RNA quarterly operating income is -$131.52 million

quarterly net income

-$115.77M
RNA quarterly net profit is -$115.77 million

Quarterly EPS

-$0.90
RNA quarterly earnings per share is -$0.90

TTM revenue:

$8.93M-$1.97M(-18.08%)
March 31, 2025

Summary

  • As of today (May 29, 2025), RNA TTM revenue is $8.93 million, with the most recent change of -$1.97 million (-18.08%) on March 31, 2025.
  • Over the past year, RNA TTM revenue has dropped by -$1.94 million (-17.87%).
  • RNA TTM revenue is now -18.08% below its all-time high of $10.90 million, reached on December 31, 2024.

Performance

3-month change

-18.08%

1-year change

-17.87%

3-year change

+6.06%

5-year change

+142.78%

RNA TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

21.39%
RNA TTM revenue is higher than 21.39% of companies in Healthcare sector

Analysts estimate

$8.49M
RNA TTM revenue is currently +5.14% higher than the consensus analysts' forecast

Range

All-time high

$10.90M
RNA TTM revenue is currently -18.08% below its historical high of $10.90 million

3-year low

$7.99M
RNA TTM revenue is currently +11.76% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
RNA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
RNA next earnings announcement is scheduled for Aug 8, 2025

OtherRNAincome statement metrics

TTM gross profit

-
RNA TTM gross profit value is unknown

TTM operating profit

-$433.27M
RNA TTM operating income is -$433.27 million

TTM net income

-$369.22M
RNA TTM net profit is -$369.22 million

TTM EPS

-$3.00
RNA TTM earnings per share is -$3.00

RNA Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.0%-55.6%-17.9%
3 y3 years+16.9%-12.4%+6.1%
5 y5 years+369.9%+15.8%+142.8%

RNA Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+18.1%-55.6%at low-18.1%+11.8%
5 y5-yearat high+369.9%-55.6%+15.8%-18.1%+142.8%
alltimeall timeat high+2775.2%-55.6%+602.2%-18.1%+3885.3%

RNA Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.57M(-47.1%)
$8.93M(-18.1%)
Dec 2024
$10.90M(+14.0%)
$2.97M(+27.3%)
$10.90M(+7.7%)
Sep 2024
-
$2.34M(+14.2%)
$10.12M(-4.5%)
Jun 2024
-
$2.04M(-42.3%)
$10.60M(-2.5%)
Mar 2024
-
$3.54M(+61.6%)
$10.87M(+13.7%)
Dec 2023
$9.56M(+3.6%)
$2.19M(-22.2%)
$9.56M(-5.7%)
Sep 2023
-
$2.82M(+21.7%)
$10.14M(+3.4%)
Jun 2023
-
$2.32M(+3.7%)
$9.80M(+1.4%)
Mar 2023
-
$2.23M(-19.4%)
$9.66M(+4.7%)
Dec 2022
$9.22M
$2.77M(+11.6%)
$9.22M(+11.0%)
Sep 2022
-
$2.48M(+14.0%)
$8.31M(+4.0%)
Jun 2022
-
$2.18M(+21.3%)
$7.99M(-5.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
$1.79M(-3.1%)
$8.42M(-9.7%)
Dec 2021
$9.33M(+37.4%)
$1.85M(-14.4%)
$9.33M(-3.0%)
Sep 2021
-
$2.16M(-17.0%)
$9.62M(+4.5%)
Jun 2021
-
$2.61M(-3.6%)
$9.20M(+13.1%)
Mar 2021
-
$2.70M(+26.2%)
$8.13M(+19.8%)
Dec 2020
$6.79M(+192.7%)
$2.14M(+22.7%)
$6.79M(+11.4%)
Sep 2020
-
$1.75M(+13.3%)
$6.09M(+21.9%)
Jun 2020
-
$1.54M(+13.5%)
$4.99M(+35.8%)
Mar 2020
-
$1.36M(-6.0%)
$3.68M(+58.6%)
Dec 2019
$2.32M(+511.9%)
$1.45M(+122.3%)
$2.32M(+165.3%)
Sep 2019
-
$650.00K(+190.2%)
$874.00K(+290.2%)
Jun 2019
-
$224.00K
$224.00K
Dec 2018
$379.00K
-
-

FAQ

  • What is Avidity Biosciences annual revenue?
  • What is the all time high annual revenue for Avidity Biosciences?
  • What is Avidity Biosciences annual revenue year-on-year change?
  • What is Avidity Biosciences quarterly revenue?
  • What is the all time high quarterly revenue for Avidity Biosciences?
  • What is Avidity Biosciences quarterly revenue year-on-year change?
  • What is Avidity Biosciences TTM revenue?
  • What is the all time high TTM revenue for Avidity Biosciences?
  • What is Avidity Biosciences TTM revenue year-on-year change?

What is Avidity Biosciences annual revenue?

The current annual revenue of RNA is $10.90M

What is the all time high annual revenue for Avidity Biosciences?

Avidity Biosciences all-time high annual revenue is $10.90M

What is Avidity Biosciences annual revenue year-on-year change?

Over the past year, RNA annual revenue has changed by +$1.34M (+13.99%)

What is Avidity Biosciences quarterly revenue?

The current quarterly revenue of RNA is $1.57M

What is the all time high quarterly revenue for Avidity Biosciences?

Avidity Biosciences all-time high quarterly revenue is $3.54M

What is Avidity Biosciences quarterly revenue year-on-year change?

Over the past year, RNA quarterly revenue has changed by -$1.97M (-55.60%)

What is Avidity Biosciences TTM revenue?

The current TTM revenue of RNA is $8.93M

What is the all time high TTM revenue for Avidity Biosciences?

Avidity Biosciences all-time high TTM revenue is $10.90M

What is Avidity Biosciences TTM revenue year-on-year change?

Over the past year, RNA TTM revenue has changed by -$1.94M (-17.87%)
On this page